AN2 Therapeutics Target Price

Where could ANTX trade next? Consensus target price: $9.

Get informed when a big investor buys or sells

+ Follow

Share Price

$5.98

Average Target Price

$9.00

50.5% upside

2 analysts in the last 4 months

High: $9 | Low: $9

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-07-20	Guggenheim	$9	50.5% upside
2026-05-14	Leerink PartnersJoseph Schwartz	$9	50.5% upside
2025-05-05	JMP SecuritiesRoy Buchanan	$2	66.6% downside
2024-07-03	Leerink PartnersJoseph Schwartz	$5	16.4% downside
2024-05-16	Evercore ISILiisa Bayko	$2	66.6% downside
2024-04-02	JMP SecuritiesRoy Buchanan	$6	0.3% upside
2022-11-14	Leerink Partners	$25	318.1% upside
2022-04-19	Evercore ISI	$25	318.1% upside
2022-04-19	Oppenheimer	$22	267.9% upside

AN2 Therapeutics (ANTX) FAQ

AN2 Therapeutics posts a target price of $9. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $9 for ANTX means covering analysts, on average, see the stock 50.5% upside of $5.98 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for ANTX's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; AN2 Therapeutics's other metric pages and overview cover the third.